You can get access to information on Huons and its development of new products

• 46
  Huons N Completes Expansion of Chuncheon Plant, Boosting Competitiveness in Health Functional Food Production PR · 2026.07.09
• 45
  Huons Advances Phase 2 Clinical Trial of Peptide-Based Dry Eye Disease Drug 'HUC1-394' with First Patient Enrollment 홍보팀 · 2026.07.03
• 44
  Huons N Completes Merger with Health Functional Food Manufacturing Subsidiary 'BioRosette' PR · 2026.07.02
• 43
  Huons Completes Merger with Huons Life Sciences PR · 2026.06.26
• 42
  Huons Selected for National Drug Development Program to Advance Fibrostenotic Crohn’s Disease Treatment huons · 2026.06.23
• 41
  PanGen Biotech Wins Government Research Project for SFTS Therapeutic Antibody Development PR · 2026.06.22
• 40
  Huons Reports 2026 Q1 Results: Revenue of KRW 141.9 Billion, Operating Loss of 649 Million PR · 2026.05.12
• 39
  Huons to Launch Korea’s First Preservative-free Multi-dose Olopatadine 'Hurotadine Eye Drops 0.7%' PR · 2026.05.11
• 38
  Huons N Participates in Vitafoods Europe 2026... Expanding Global Partnerships PR · 2026.05.07
• 37
  Huons N to Absorb Wholly Owned Subsidiary BioRosette Through Merger PR · 2026.04.30

All Title Content Writer